Role of membrane lipids in myocardial cytoprotection;Role des lipides membranaires dans la cytoprotection myocardique

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 2, 2000, Pages 175-182

  Grynberg, A ^a  

^a Faculte de Pharmacie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; FATTY ACID; MEMBRANE LIPID; PHOSPHOLIPASE; PHOSPHOLIPID; TRIMETAZIDINE; GLUCOSE;

ANGINA PECTORIS; CELL PROTECTION; DRUG ACTIVITY; ENERGY METABOLISM; FATTY ACID METABOLISM; GLUCOSE HOMEOSTASIS; HEART CONTRACTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; PHOSPHOLIPID SYNTHESIS; REVIEW; ARTICLE; CYTOLOGY; HEART; HEART MUSCLE; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; CYTOPROTECTION; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; HEART; HUMANS; MEMBRANE LIPIDS; MITOCHONDRIA; MYOCARDIUM; PHOSPHOLIPIDS;

EID: 0034137933     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Stanley WC, Lopaschuck GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological intervenfions. Cardiovasc Res 1997 ; 33 : 243-57.
2. Opie L. The heart. Physiology and metabolism. New York : Raven Press, 1991.
3. Stephens J, Pilch P. The metabolic regulation and vesicular transport of GLUT4, the major insulin-responsive glucose transporter. Endocr Rev 1995 ; 16 : 529-46.
4. Drake AJ, Haines JR, Noble MIM. Preferential uptake of lactate by the normal myocardium in doqs. Cardiovasc Res 1980 ; 14 : 65-72.
5. McMurchie EJ. Dietary lipids and the regulation of membrane fluidity and function. In : Aloia RC, Curtain CC and Gordon LH (eds). Advances in membrane fluidity. Physiological regulation of membrane fluidity. New York : Alan R Liss Inc, 1988 ; 3 : 189-237.
6. Lands WE, Inoue M, Sigiura Y, Okuyama H. Selective incorporation of polyunsaturated fatty acids into phosphatidylcholine by rat liver microsomes. J Biol Chem 1982 ; 257 : 14968-72.
7. McDonald JIS, Sprecher H. Phospholipid fatty acid remodelling in mammalian cells. Biochim Biophys Acta 1991 ; 1084 : 105-21.
8. Grynberg A, Nalbone G, Degois M, Leonardi J, Athias P, Lafont H. Activities of some enzymes of phospholipid metabolism in cultured rat ventricular myocytes in normoxic and hypoxic conditions. Biochim Biophys Acta 1988 ; 958 : 24-30.
9. Vance DE. Glycerolipid biosynthesis in eukaryotes. In : Vance DE, Vance JE (eds). Biochemistry of lipids, lipoproteins and membrane. Amsterdam : Elsevier, 1996 : 153-80.
10. Rausch B, Bode C, Piper HM et al. Palmitate uptake by calcium tolerant, adult rat myocardial single cells: evidence for an albumin mediated transport across sarcolemma. J Mol Cell Cardiol 1987; 19 : 159-66.
11. Stremmel W. Fatty acid uptake by isolated rat heart myocytes represents a carrier mediated transport process. J Clin Invest 1988 ; 81 : 844-52.
12. Schulz H. Beta-oxydation of fatty acids. Biochim. Biophys Acta 1991 ; 1081 : 109-20.
13. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acelyl-CoA carboxylose regulation of fatty acid oxidation in the heart. J Biol Chem 1993 ; 268 : 25836-45.
14. Pauly DF, Kirk KA, McMillin JB. Carnitine polmitoyl transferase in cardiac ischemia. A potential site for altered fatty acid metabolism. Circ Res 1991 ; 68 : 1085-94.
15. Wojtczak L, Schönfeld P. Effect of fatty acid on energy coupling process in mitochondria. Biochim Biophys Acta 1993 ; 1183 : 41-57.
16. Hütter JF, Soboll S. Role of fatty acid metabolites in the developpement of myocardial ischemic damage. Int J Biochem 1992 ; 24 : 399-403.
17. Van der Vusse, GJ, Reneman RS, Van Bilsen M. Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes and consequences. Prostaglandins Leukot Essent Fatty Acids 1997 ; 57 : 85-93.
18. Grynberg A, Fournier A, Sergiel JP, Athias P. Membrane DHA versus EPA and the beating function of the cardiomyocytes through the adrenergic receptors. Lipids 1996 ; 31 : S205-S210.
19. Deigner HP, Kinscherf R. Modulating apoptosis: current applications and prospects for future drug development. Curr Med Chem 1999 ; 6 : 399-414.
20. Subbaramaiah K, Chung WJ, Dannenberg AJ. Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 1998 ; 273 : 32943-9.
21. Gudbjarnason S, Benediksdottir VE. Coregulation of adrenoceptors and the lipid environment in heart muscle during repeated adrenergic stimulation. J Mol Cell Cardiol 1995 ; 27 : 243-51.
22. Gudmundsdottir E, Benediksdottir VE, Gudbjarnason S. Combined effect of age and dietary fat on beta-receptors and Cachannels in rat heart. Am J Physiol 1991 ; 260 : H66-H72.
23. Pepe S, McLennan PL. Modulation of myocardial oxygen requirements by dietary lipids in the isolated erythrocyte perfused working rat heart. J Mol Cell Cordiol 1992 ; 24 : S115.
24. Ogoshi Y, Goto Y, Futaki S, Yaku H, Kawaguchi O, Suga H. Increased oxygen cost of contractility in stunned myocardium of dog. Circ Res 1991 ; 69 : 975-88.
25. Demaison L, Sergiel JP, Moreau D, Grynberg A. Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1994 ; 1227 : 53-9.
26. Pinson A, Padieu P. Erucic acid oxidation by beating heart cells in culture. Febs Lett 1974 ; 39 : 88-90.
27. Przyrembel H, Sewell AC. Defects in long chain fatty acid oxidation as a cause of cardiomyopathy. In: Böhles H, Hofstetter R, Sewell AC (eds). Metabolic Cardiomyopathy. Stuttgart : Wissenschaftliche Verlagsgesellschaft, 1995 : 77-85.
28. Rupp H, Schultze W, Vetter R. Dietary medium-chain triglycerides can prevent changes in myosin and SR due to CPT-1 inhibition by etomoxir. Am J Physiol 1995 ; 269 : R630-R640.
29. Lopaschuk GD, Wambolt RB, Barr RL. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 1993 ; 264 : 135-44.
30. Böhles H, Noppeney T, Akcetin Z, Rein J, Von der Emde J. The effect of preoperative L-carnitine supplementation on myocardial metabolism during aorta-coronary bypass surgery. Curr Ther Res 1986 ; 39 : 429-35.
31. Clarke B, Wyatt KM, McCormack JG. Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism. J Mol Cell Cardiol 1996 ; 28 : 341-50.
32. Meurin P, Sellier P. Trimétazidine : du mécanisme d'action à l'efficacité clinique dans l'angor stable. lettre pharmacol 1997 ; 11 : 20-6.
33. Lavanchy N, Martin J, Rossi A. Anti-ischemic effects of Trimetazidine : 3IP-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 1987 ; 286 : 97-110.
34. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat myocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 1994 ; 26 : 949-58.
35. Pichon G, Rousseau D, Héliès C et al. Contrôle par la trimétazidine de la balance des substrats énergétiques du myocyte ventriculaire. Arch Mal Cœur 1999 ; 92 : 496.
36. Mody FV, Singh BN, Mohiuddin IH et al. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography. Am J Cardiol 1998 ; 82 : 42K-49K.
37. Sentex E, Sergiel JP, Lucien A, Grynberg A. Trimetazidine increases phospholipid turnover in ventricular myocytes. Mol Cell Biochem 1997 ; 175 : 153-62.
38. Sentex E, Sergiel JP, Lucien A, Grynberg A. Is the cytoprotective effect of trimetazidine associated with lipid metabolism? Am J Cardiol 1998 ; 82 : 18K-24K.